Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$10.41
-1.8%
$12.83
$5.45
$18.98
$341.45M2.03171,958 shs273,019 shs
Outset Medical, Inc. stock logo
OM
Outset Medical
$18.98
-3.0%
$16.15
$5.85
$72.60
$336.33M2.14127,575 shs1.42 million shs
Penumbra, Inc. stock logo
PEN
Penumbra
$256.75
-0.1%
$274.48
$148.00
$310.00
$9.94B0.5451,908 shs859,137 shs
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$5.51
+0.9%
$6.38
$4.54
$10.79
$346.52M0.69540,772 shs438,259 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
NeuroPace, Inc. stock logo
NPCE
NeuroPace
0.00%-5.96%-41.12%-15.37%+55.84%
Outset Medical, Inc. stock logo
OM
Outset Medical
0.00%-4.91%+5.74%+80.93%-70.78%
Penumbra, Inc. stock logo
PEN
Penumbra
0.00%+0.18%-4.45%-10.26%+43.79%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
0.00%-2.82%-6.29%-36.59%-7.24%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
NeuroPace, Inc. stock logo
NPCE
NeuroPace
3.7085 of 5 stars
3.45.00.00.02.54.20.6
Outset Medical, Inc. stock logo
OM
Outset Medical
1.3985 of 5 stars
3.53.00.00.00.00.80.0
Penumbra, Inc. stock logo
PEN
Penumbra
4.634 of 5 stars
3.45.00.03.71.52.51.9
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
2.1081 of 5 stars
3.11.00.00.01.93.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
NeuroPace, Inc. stock logo
NPCE
NeuroPace
2.83
Moderate Buy$15.5048.90% Upside
Outset Medical, Inc. stock logo
OM
Outset Medical
3.00
Buy$27.0042.26% Upside
Penumbra, Inc. stock logo
PEN
Penumbra
2.88
Moderate Buy$302.4017.78% Upside
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
2.29
Hold$10.1684.34% Upside

Current Analyst Ratings Breakdown

Latest PEN, NPCE, TMCI, and OM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/28/2025
NeuroPace, Inc. stock logo
NPCE
NeuroPace
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$18.00
5/21/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform$14.00 ➝ $21.00
5/15/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/14/2025
NeuroPace, Inc. stock logo
NPCE
NeuroPace
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$14.00 ➝ $16.00
5/14/2025
NeuroPace, Inc. stock logo
NPCE
NeuroPace
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$17.00 ➝ $17.00
5/9/2025
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$10.00 ➝ $8.60
5/8/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$12.00 ➝ $14.00
4/24/2025
Penumbra, Inc. stock logo
PEN
Penumbra
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$320.00 ➝ $330.00
4/24/2025
Penumbra, Inc. stock logo
PEN
Penumbra
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
4/24/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$301.00 ➝ $318.00
4/24/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$315.00 ➝ $330.00
(Data available from 6/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$79.91M4.27N/AN/A$0.27 per share38.56
Outset Medical, Inc. stock logo
OM
Outset Medical
$113.69M2.96N/AN/A$7.49 per share2.53
Penumbra, Inc. stock logo
PEN
Penumbra
$1.19B8.32$2.89 per share88.99$29.99 per share8.56
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$209.36M1.66N/AN/A$1.81 per share3.04
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-$27.14M-$0.84N/AN/AN/A-29.42%-190.84%-25.08%8/12/2025 (Estimated)
Outset Medical, Inc. stock logo
OM
Outset Medical
-$127.98M-$29.15N/AN/A-98.74%-143.62%-37.50%8/6/2025 (Estimated)
Penumbra, Inc. stock logo
PEN
Penumbra
$14.01M$1.06242.2251.252.293.41%11.14%8.40%7/29/2025 (Estimated)
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$55.74M-$0.85N/AN/AN/A-25.14%-48.69%-24.59%8/5/2025 (Estimated)

Latest PEN, NPCE, TMCI, and OM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2025Q1 2025
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-$0.26-$0.21+$0.05-$0.21$21.85 million$22.52 million
5/8/2025Q1 2025
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$0.31-$0.25+$0.06-$0.25$52.07 million$52.57 million
5/7/2025Q1 2025
Outset Medical, Inc. stock logo
OM
Outset Medical
-$0.97-$3.66-$2.69-$3.66$27.81 million$29.75 million
4/23/2025Q1 2025
Penumbra, Inc. stock logo
PEN
Penumbra
$0.66$0.83+$0.17$1.00$315.72 million$324.14 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
NeuroPace, Inc. stock logo
NPCE
NeuroPace
N/AN/AN/AN/AN/A
Outset Medical, Inc. stock logo
OM
Outset Medical
N/AN/AN/AN/AN/A
Penumbra, Inc. stock logo
PEN
Penumbra
N/AN/AN/AN/AN/A
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
NeuroPace, Inc. stock logo
NPCE
NeuroPace
2.46
6.63
5.70
Outset Medical, Inc. stock logo
OM
Outset Medical
0.57
8.37
6.74
Penumbra, Inc. stock logo
PEN
Penumbra
0.02
6.30
3.68
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
0.51
4.50
3.36

Institutional Ownership

CompanyInstitutional Ownership
NeuroPace, Inc. stock logo
NPCE
NeuroPace
78.83%
Outset Medical, Inc. stock logo
OM
Outset Medical
N/A
Penumbra, Inc. stock logo
PEN
Penumbra
88.88%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
84.08%

Insider Ownership

CompanyInsider Ownership
NeuroPace, Inc. stock logo
NPCE
NeuroPace
20.50%
Outset Medical, Inc. stock logo
OM
Outset Medical
2.40%
Penumbra, Inc. stock logo
PEN
Penumbra
5.00%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
27.72%
CompanyEmployeesShares OutstandingFree FloatOptionable
NeuroPace, Inc. stock logo
NPCE
NeuroPace
17032.80 million26.08 millionOptionable
Outset Medical, Inc. stock logo
OM
Outset Medical
52017.72 million17.30 millionNot Optionable
Penumbra, Inc. stock logo
PEN
Penumbra
4,50038.73 million36.79 millionOptionable
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
25062.89 million45.46 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
NeuroPace stock logo

NeuroPace NASDAQ:NPCE

$10.41 -0.19 (-1.79%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$10.52 +0.11 (+1.05%)
As of 06/20/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Outset Medical stock logo

Outset Medical NASDAQ:OM

$18.98 -0.59 (-3.01%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$18.99 +0.01 (+0.05%)
As of 06/20/2025 04:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Penumbra stock logo

Penumbra NYSE:PEN

$256.75 -0.26 (-0.10%)
Closing price 06/20/2025 03:59 PM Eastern
Extended Trading
$256.87 +0.12 (+0.05%)
As of 06/20/2025 05:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Treace Medical Concepts stock logo

Treace Medical Concepts NASDAQ:TMCI

$5.51 +0.05 (+0.92%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$5.51 0.00 (0.00%)
As of 06/20/2025 05:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.